Trivarx Ltd has released a press release.
AGM Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from TrivarX
- MEB Signs Clinical Trial Agreement with MedBridge Healthcare
- Request For FDA Breakthrough Device Designation Submitted
- Patent Granted to Monitor Stress Conditions Using Heartrate
- Entitlement Issue Results
- Entitlement Offer Booklet
Later from TrivarX
- Global Master License & Services Agreement with Compass
- Update on Breakthrough Device Program
- US FDA advises further data needed for MEBsleep approval
- Consumer Mental Health App Initial testing phase commenced
- Medibio Granted CE Mark Approval for MEBsleep
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX